Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

The cystic fibrosis lung microbiome exposes novel members of the genus Streptococcus.

EF 2009-10

Résumé
Cystic fibrosis, CF, is a genetic disease, affecting approximately 4000 Canadians. In the lungs, thick mucus builds up that allows bacterial infections to occur, leading to damaged surrounding tissues. With many advances in modern medicine, CF patients' life expectancy is at the highest now than it has ever been. Despite this, lung infections caused by bacteria are the primary cause of death in CF patients. In healthy people, there are a large group of bacteria called the Streptococcus family that are normally found in the respiratory tract and cause no damage. The Streptococcus family is an interesting group of bacteria because they can have positive and negative effects on humans. In CF patients it has been shown that these bacteria can be very harmful and a cause of the bacterial infections. Recent studies have looked at CF patients and found new species of bacteria belonging to the Streptococcus group, that have previously been undiscovered and unstudied. This study will look at how these new Streptococcus bacteria interact within the CF patient and if they have any detrimental effect. Knowing if these new bacteria are negative or positive to the human host will allow further research and treatment study. We will also learn what kind of negative effects these new bacteria have on the host and if they interact with any other bacteria in the lung. Some bacteria work together in the same environment to make an infection worse, as may be the case here. By understanding how these new Streptococcus bacteria work in the CF patient, we can find new ways to treat these infections and find alternative treatment for this disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
199724
Name
Eshaghurshan Christina S
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
The cystic fibrosis lung microbiome exposes novel members of the genus Streptococcus.
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
16s Ribosomal Rna Sequencing; Bacterial Pathogenesis; Cystic Fibrosis; Novel Species; Streptococcus Species; Virulence Factors
Abstract
Cystic fibrosis, CF, is a genetic disease, affecting approximately 4000 Canadians. In the lungs, thick mucus builds up that allows bacterial infections to occur, leading to damaged surrounding tissues. With many advances in modern medicine, CF patients' life expectancy is at the highest now than it has ever been. Despite this, lung infections caused by bacteria are the primary cause of death in CF patients. In healthy people, there are a large group of bacteria called the Streptococcus family that are normally found in the respiratory tract and cause no damage. The Streptococcus family is an interesting group of bacteria because they can have positive and negative effects on humans. In CF patients it has been shown that these bacteria can be very harmful and a cause of the bacterial infections. Recent studies have looked at CF patients and found new species of bacteria belonging to the Streptococcus group, that have previously been undiscovered and unstudied. This study will look at how these new Streptococcus bacteria interact within the CF patient and if they have any detrimental effect. Knowing if these new bacteria are negative or positive to the human host will allow further research and treatment study. We will also learn what kind of negative effects these new bacteria have on the host and if they interact with any other bacteria in the lung. Some bacteria work together in the same environment to make an infection worse, as may be the case here. By understanding how these new Streptococcus bacteria work in the CF patient, we can find new ways to treat these infections and find alternative treatment for this disease.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Eshaghurshan, Christina S
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~